← SynDRA
BAMBUTEROL
SynDRA canonical compound SYN0011775 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | ADRB2 |
|---|
| Mechanism of action | Adrenergic receptor agonist |
|---|
| Indication | asthma |
|---|
| Disease area | pulmonary |
|---|
All known targets
- ADRB2
- BCHE
- CYP2D6
- ACHE
- Ache
- Bche
- ADRB1
Mechanisms of action (all sources)
- Adrenergic receptor agonist
- ADRB2 AGONIST
- Beta-2 adrenergic receptor agonist
- BCHE INHIBITOR
- ADRB1 PARTIAL AGONIST
- ADRB2 PARTIAL AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADORA1
- NR1I2
- NPY1R
- MMP9
- MMP1
- MLNR
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAPK1
- MAOA
- LCK
- KCNH2
- HTR6
- HTR2C
- HTR2B
- HTR2A
- HRH3
- HRH2
- HRH1
- HMGCR
- HDAC6
- GNAS
- NPY2R
- NR3C1
- ADORA2A
- OPRD1
- USP1
- TDP1
- TBXAS1
- TBXA2R
- TACR2
- TACR1
- SLC6A4
- SLC6A3
- SLC6A2
- SLC29A1
- SIGMAR1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anti-Asthmatic Agents
- Bronchodilator Agents
- Peripheral Nervous System Agents
- Respiratory System Agents
- Adrenergic Agents
- Adrenergic Agonists
- Adrenergic beta-2 Receptor Agonists
- Adrenergic beta-Agonists
- Neurotransmitter Agents
- Reproductive Control Agents
- Sympathomimetics
- Tocolytic Agents
ATC classes
- R03C · ADRENERGICS FOR SYSTEMIC USE
- R03A · ADRENERGICS, INHALANTS
Cross-references
Synonyms
- bambudil
- terbutaline bisdimethylcarbamate
- (+/-)-Bambuterol
- bambuterol hydrochloride
- bambuterol HCl
- Bambec
- Bambuterolum
- Oxeol
- Bambuterolum [Latin]
- Terbutaline bisdimethylcarbamate
- Bambec (TN)
- Bambuterol (INN)
- Bambuterol [BAN:INN]
- KWD-2183
- Oxeol (TN)
- Terbutaline bis(dimethylcarbamate)
- [3-[2-(tert-butylamino)-1-hydroxyethyl]-5-(dimethylcarbamoyloxy)phenyl] N,N-dimethylcarbamate
- (+-)-5-(2-(tert-Butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate)
- 5-(2-(tert-butylamino)-1-hydroxyethyl)-3-phenylene bis(dimethylcarbamate)
- 5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diyl bis(dimethylcarbamate)
- Y1850G1OVC
- CHEBI:553827
- RefChem:116411
- DTXCID1028106
- R03CC12
- BAMBUTEROL [INN]
- (+/-)-Bambuterol;KWD-2183
- Bambuterol [INN:BAN]
- UNII-Y1850G1OVC
- terbutaline bis(dimethylcarbamate)
- BAMBUTEROL [MI]
- Terbutaline Impurity 93
- Prestwick0_000361
- Prestwick1_000361
- Prestwick2_000361
- Prestwick3_000361
- SCHEMBL4431
- BAMBUTEROL [WHO-DD]
Reported adverse events
- Headache
- Nausea
- Palpitations
- Tachycardia
- Tremor
- Anxiety
- Somnolence
- Asthenia
- Dizziness
- Extrasystoles
- Insomnia
- Nervousness
Look up BAMBUTEROL in the interactive SynDRA portal →